Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov;8(11):909-13.

The future of G protein-coupled receptors as targets in drug discovery

Affiliations
  • PMID: 16254784

The future of G protein-coupled receptors as targets in drug discovery

Kenneth Lundstrom. IDrugs. 2005 Nov.

Abstract

G protein-coupled receptors (GPCRs) represent the most abundant drug targets today. A large number of GPCR-based drugs have already been developed for a variety of indications in human disease. However, orphan receptors with unidentified ligands serve as potential targets still to be explored. Moreover, research on the interaction of GPCRs with different molecules in the signal transduction pathways, and further studies on receptor dimerization may also lead to the discovery of new drugs. Structure-based drug design will eventually play a key role in generating better and more selective drugs more rapidly when high-resolution structures of GPCRs can be provided by expression, purification and crystallography technologies.

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

Substances